Skip to content

A randomized controlled trial for Timolol and PDL in the treatment of ulcerated infantile hemangioma

Topical Timolol and Pulse Dye Laser for ulcerated infantile hemangioma: a randomized controlled study of difference in healing times.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024730
Enrollment
Unknown
Registered
2019-07-25
Start date
2019-09-01
Completion date
Unknown
Last updated
2019-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infantile Hemangioma

Interventions

Topical Timolol:Topical Timolol
Pulse Dye Laser:Pulse Dye Laser

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: 1. Patients who are diagnosed with infantile hemangioma according to ISSVA diagnostic criteria; 2. Patients less than 1 year old who are suffering from proliferated infantile hemangioma; 3. Patients with ulcerated infantile hemangiomas presented to Shanghai Ninth People's Hospital during the time period of September,2019 to December, 2020. The duration from initiation of ulceration to the first visit to our clinic center should be less than 15 days; 4. Untreated lesions (patients who didnt take oral or topical ßreceptor-blocker or be treated with laser before); 5. Patients guardians who are willing to cooperate with treatment and subsequent visits.

Exclusion criteria

Exclusion criteria: 1. Patients who have been diagnosed with severe immune deficiency or congenital diseases; 2. Patients with severe infantile hemangioma who should take oral Propranolol and those who are receiving other treatments of ulcerations; 3. Patients participating in other clinical trials; 4. Patients who are allergic to ß receptor-blocker drugs.

Design outcomes

Primary

MeasureTime frame
duration of ulcer healing;

Countries

China

Contacts

Public ContactLin Xiaoxi

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine

linxiaoxi@126.com+86 13701997136

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026